|
DE3050328C2
(de)
|
1980-04-07 |
1987-04-02 |
Berman, Joel, d/b/a Joel Berman Associates, New York, N.Y. |
Fensterrollo
|
|
US4816567A
(en)
*
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
EP0381296B1
(en)
|
1984-04-30 |
1994-11-30 |
THE PROCTER & GAMBLE COMPANY |
Kit for use in the treatment of osteoporosis
|
|
JPS61134325A
(ja)
|
1984-12-04 |
1986-06-21 |
Teijin Ltd |
ハイブリツド抗体遺伝子の発現方法
|
|
US4631211A
(en)
*
|
1985-03-25 |
1986-12-23 |
Scripps Clinic & Research Foundation |
Means for sequential solid phase organic synthesis and methods using the same
|
|
US5618920A
(en)
|
1985-11-01 |
1997-04-08 |
Xoma Corporation |
Modular assembly of antibody genes, antibodies prepared thereby and use
|
|
US5225539A
(en)
*
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
US5324819A
(en)
|
1988-04-08 |
1994-06-28 |
Stryker Corporation |
Osteogenic proteins
|
|
US5266683A
(en)
*
|
1988-04-08 |
1993-11-30 |
Stryker Corporation |
Osteogenic proteins
|
|
US5344654A
(en)
|
1988-04-08 |
1994-09-06 |
Stryker Corporation |
Prosthetic devices having enhanced osteogenic properties
|
|
US5010175A
(en)
|
1988-05-02 |
1991-04-23 |
The Regents Of The University Of California |
General method for producing and selecting peptides with specific properties
|
|
US5298852A
(en)
*
|
1988-12-22 |
1994-03-29 |
Robert Bosch Gmbh |
Arrangement for and method of controlling a three-phase-generator in a vehicle
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5561173A
(en)
*
|
1990-06-19 |
1996-10-01 |
Carolyn M. Dry |
Self-repairing, reinforced matrix materials
|
|
AU658396B2
(en)
*
|
1991-03-06 |
1995-04-13 |
Merck Patent Gesellschaft Mit Beschrankter Haftung |
Humanized and chimeric monoclonal antibodies
|
|
US5656593A
(en)
*
|
1991-03-11 |
1997-08-12 |
Creative Biomolecules, Inc. |
Morphogen induced periodontal tissue regeneration
|
|
US5118667A
(en)
*
|
1991-05-03 |
1992-06-02 |
Celtrix Pharmaceuticals, Inc. |
Bone growth factors and inhibitors of bone resorption for promoting bone formation
|
|
CA2078539C
(en)
|
1991-09-18 |
2005-08-02 |
Kenya Shitara |
Process for producing humanized chimera antibody
|
|
ES2136092T3
(es)
|
1991-09-23 |
1999-11-16 |
Medical Res Council |
Procedimientos para la produccion de anticuerpos humanizados.
|
|
KR100259827B1
(ko)
|
1991-11-04 |
2000-06-15 |
브루스 엠. 에이센, 토마스 제이 데스로저 |
재조합 골형태 형성 단백질 헤테로다이머, 그 조성물 및 사용방법
|
|
GB9125979D0
(en)
|
1991-12-06 |
1992-02-05 |
Wellcome Found |
Antibody
|
|
US5863537A
(en)
|
1992-02-19 |
1999-01-26 |
Schering Corporation |
Humanized monoclonal antibodies against human interleukin-4
|
|
US5733743A
(en)
|
1992-03-24 |
1998-03-31 |
Cambridge Antibody Technology Limited |
Methods for producing members of specific binding pairs
|
|
US5639641A
(en)
|
1992-09-09 |
1997-06-17 |
Immunogen Inc. |
Resurfacing of rodent antibodies
|
|
IT1255522B
(it)
|
1992-09-24 |
1995-11-09 |
Ubaldo Conte |
Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
|
|
JP3347144B2
(ja)
*
|
1993-01-12 |
2002-11-20 |
ジェネンテク，インコーポレイテッド |
骨成長を誘発させるためのＴＧＦ−β製剤
|
|
TW303299B
(enExample)
*
|
1993-07-22 |
1997-04-21 |
Lilly Co Eli |
|
|
US5705154A
(en)
|
1995-03-08 |
1998-01-06 |
Schering Corporation |
Humanized monoclonal antibodies against human interleukin-4
|
|
US5550134A
(en)
*
|
1995-05-10 |
1996-08-27 |
Eli Lilly And Company |
Methods for inhibiting bone loss
|
|
DE19647853A1
(de)
*
|
1996-11-19 |
1998-05-20 |
Bioph Biotech Entw Pharm Gmbh |
Verbindungen mit verbesserter knorpel- und/oder knocheninduzierender Aktivität
|
|
US5939039A
(en)
*
|
1997-01-16 |
1999-08-17 |
Orthovita, Inc. |
Methods for production of calcium phosphate
|
|
AU6267798A
(en)
|
1997-02-07 |
1998-08-26 |
Stryker Corporation |
Matrix-free osteogenic devices, implants and methods of use thereof
|
|
US20020098222A1
(en)
*
|
1997-03-13 |
2002-07-25 |
John F. Wironen |
Bone paste
|
|
US7041641B2
(en)
*
|
1997-03-20 |
2006-05-09 |
Stryker Corporation |
Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects
|
|
EP0984795B1
(en)
*
|
1997-04-22 |
2003-09-24 |
Washington Research Foundation |
Bone grafts and prostheses coated with tartrate-resistant acid phosphatase
|
|
US6025538A
(en)
|
1998-11-20 |
2000-02-15 |
Musculoskeletal Transplant Foundation |
Compound bone structure fabricated from allograft tissue
|
|
ES2639020T3
(es)
*
|
1998-11-27 |
2017-10-25 |
Ucb Pharma S.A. |
Composiciones y métodos para incrementar la mineralización de la substancia ósea
|
|
US20040009535A1
(en)
*
|
1998-11-27 |
2004-01-15 |
Celltech R&D, Inc. |
Compositions and methods for increasing bone mineralization
|
|
US6756480B2
(en)
*
|
2000-04-27 |
2004-06-29 |
Amgen Inc. |
Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
|
|
US20030082233A1
(en)
|
2000-12-01 |
2003-05-01 |
Lyons Karen M. |
Method and composition for modulating bone growth
|
|
WO2002067978A1
(en)
|
2001-02-23 |
2002-09-06 |
Wyeth |
Chondrogenic potential of human bone marrow-derived cd105+ cells by bmp
|
|
US6949251B2
(en)
*
|
2001-03-02 |
2005-09-27 |
Stryker Corporation |
Porous β-tricalcium phosphate granules for regeneration of bone tissue
|
|
BR0209563A
(pt)
|
2001-05-11 |
2004-12-07 |
Genome Theraupeutics Corp |
ácido nucleico, polipeptìdeo, vetor, célula, anticorpo, métodos de diagnosticar um fenótipo e um paciente como expressando um ácido nucleico e de identificar agentes que modulam a atividade de um ácido nucleico e de uma proteìna e lrp5, lrp6, ou hbm e compostos que modulam a interação de dkk com o caminho de sinalização wnt, composição para modular a massa óssea e/ou os nìveis de lipìdeo em um paciente, animal transgênico, embrião e modelo de animal, e, agente
|
|
TWI267378B
(en)
*
|
2001-06-08 |
2006-12-01 |
Wyeth Corp |
Calcium phosphate delivery vehicles for osteoinductive proteins
|
|
TR201809678T4
(tr)
*
|
2001-06-26 |
2018-07-23 |
Amgen Fremont Inc |
Opgl ye karşi antikorlar.
|
|
WO2003070288A2
(en)
|
2001-10-12 |
2003-08-28 |
Inframat Corporation |
Coated implants and methods of coating implants
|
|
CA2465499A1
(en)
|
2001-11-08 |
2003-05-15 |
Merck & Co., Inc. |
Compositions and methods for treating osteoporosis
|
|
AU2003207512B2
(en)
*
|
2002-01-10 |
2008-06-12 |
Osteotrophin Llc |
Treatment of bone disorders with skeletal anabolic drugs
|
|
JP2005519067A
(ja)
*
|
2002-01-17 |
2005-06-30 |
ザ ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム |
トロンビンペプチド誘導体を用いた骨成長および軟骨形成の刺激
|
|
JP3646167B2
(ja)
|
2002-02-19 |
2005-05-11 |
独立行政法人産業技術総合研究所 |
フォスフォフォリンを含む複合生体材料
|
|
WO2003073991A2
(en)
*
|
2002-03-01 |
2003-09-12 |
Celltech R & D, Inc. |
Methods to increase or decrease bone density
|
|
US7166133B2
(en)
*
|
2002-06-13 |
2007-01-23 |
Kensey Nash Corporation |
Devices and methods for treating defects in the tissue of a living being
|
|
US20040023356A1
(en)
|
2002-06-14 |
2004-02-05 |
Robb Krumlauf |
Wise/Sost nucleic acid sequences and amino acid sequences
|
|
US7585501B2
(en)
|
2002-06-14 |
2009-09-08 |
Stowers Institute For Medical Research |
Compositions and methods for treating kidney disease
|
|
US7893218B2
(en)
|
2003-06-16 |
2011-02-22 |
Stowers Institute For Medical Research |
Antibodies that specifically bind SOST peptides
|
|
US20040002770A1
(en)
|
2002-06-28 |
2004-01-01 |
King Richard S. |
Polymer-bioceramic composite for orthopaedic applications and method of manufacture thereof
|
|
EP1539239A4
(en)
*
|
2002-07-02 |
2005-09-14 |
Smithkline Beecham Corp |
NEW STABLE FORMULATION
|
|
US20040023322A1
(en)
*
|
2002-08-01 |
2004-02-05 |
Goodheart Clyde R. |
Method of producing non-recombinant BMP-2 and use thereof
|
|
KR20040023356A
(ko)
|
2002-09-11 |
2004-03-18 |
현대모비스 주식회사 |
파킹브레이크 작동시 출발제한 시스템 및 그 방법
|
|
AU2002335562B2
(en)
|
2002-09-30 |
2007-07-05 |
Regen Biotech, Inc. |
Bone-filling composition for stimulating bone-forming and bone-consolidation comprising calcium sulfate and viscous biopolymers
|
|
JP3851602B2
(ja)
*
|
2002-10-02 |
2006-11-29 |
ペンタックス株式会社 |
骨形成治療デバイス
|
|
CA2526845A1
(en)
|
2003-06-06 |
2005-03-31 |
Wyeth |
Methods and materials for identifying agents which modulate bone remodeling and agents identified thereby
|
|
CN1835974A
(zh)
|
2003-06-16 |
2006-09-20 |
细胞技术研究与发展公司 |
对硬化素特异的抗体和用于增加骨矿化的方法
|
|
US7943393B2
(en)
|
2003-07-14 |
2011-05-17 |
Phynexus, Inc. |
Method and device for extracting an analyte
|
|
US6976816B2
(en)
|
2003-08-01 |
2005-12-20 |
Dana Corporation |
Combination lock washer and spindle bearing assembly
|
|
MY141763A
(en)
*
|
2003-09-18 |
2010-06-30 |
Novartis Ag |
Pharmaceutical products comprising bisphosphonates
|
|
US8461155B2
(en)
|
2003-09-22 |
2013-06-11 |
University Of Connecticut |
Sclerostin and the inhibition of WNT signaling and bone formation
|
|
US8895540B2
(en)
*
|
2003-11-26 |
2014-11-25 |
DePuy Synthes Products, LLC |
Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
|
|
WO2005070439A1
(en)
*
|
2004-01-09 |
2005-08-04 |
Regeneration Technologies Inc. |
Implant comprising a human muscle tissue matrix
|
|
US7189263B2
(en)
|
2004-02-03 |
2007-03-13 |
Vita Special Purpose Corporation |
Biocompatible bone graft material
|
|
US7648965B2
(en)
*
|
2004-05-14 |
2010-01-19 |
Unigene Laboratories Inc. |
Method for fostering bone formation and preservation
|
|
US7531518B2
(en)
*
|
2004-05-14 |
2009-05-12 |
Unigene Laboratories Inc. |
Method for fostering bone formation and preservation
|
|
CA2567805A1
(en)
*
|
2004-05-27 |
2005-12-15 |
Acceleron Pharma Inc. |
Tgf derepressors and uses related thereto
|
|
ES2414460T3
(es)
|
2004-08-04 |
2013-07-19 |
Amgen Inc. |
Anticuerpos para Dkk-1
|
|
JP2008517660A
(ja)
*
|
2004-10-22 |
2008-05-29 |
ザ ボード オブ トラスティーズ オブ ザ ユニバーシティ オブ イリノイ |
生物剤を送達する中空かつ多孔質の整形外科用または歯科用のインプラント
|
|
WO2006072622A2
(en)
*
|
2005-01-06 |
2006-07-13 |
Kuros Biosurgery Ag |
Supplemented matrices for the repair of bone fractures
|
|
US7531533B2
(en)
*
|
2005-01-27 |
2009-05-12 |
Asahi Kasei Pharma Corporation |
6-Membered heterocyclic compound and use thereof
|
|
US8071574B2
(en)
|
2005-02-22 |
2011-12-06 |
John Dennis Bobyn |
Implant improving local bone formation
|
|
US20060198863A1
(en)
|
2005-03-03 |
2006-09-07 |
Musculoskeletal Transplant Foundation |
Ceramic composition for filling bone defects
|
|
US7592429B2
(en)
*
|
2005-05-03 |
2009-09-22 |
Ucb Sa |
Sclerostin-binding antibody
|
|
US8003108B2
(en)
*
|
2005-05-03 |
2011-08-23 |
Amgen Inc. |
Sclerostin epitopes
|
|
JP2006320442A
(ja)
|
2005-05-18 |
2006-11-30 |
Toshiba Ceramics Co Ltd |
リン酸カルシウム系骨補填材
|
|
US20060293667A1
(en)
*
|
2005-05-19 |
2006-12-28 |
Agnes Vignery |
Bone implant device and methods of using same
|
|
WO2006135734A2
(en)
|
2005-06-10 |
2006-12-21 |
The Regents Of The University Of California |
Compositions and methods for altering bone density and bone patterning
|
|
BRPI0611800A2
(pt)
*
|
2005-06-15 |
2008-12-09 |
Schering Corp |
formulaÇço estÁvel de anticorpo
|
|
ES2402651T3
(es)
|
2005-09-09 |
2013-05-07 |
Agnovos Healthcare, Llc |
Cemento sustituto de injerto óseo de material compuesto y artículos producidos del mismo
|
|
EP2431060B1
(en)
|
2005-11-17 |
2020-04-08 |
BioMimetic Therapeutics, LLC |
Maxillofacial bone augmentation using RHPDGF-BB and a biocompatible matrix
|
|
US8158828B2
(en)
*
|
2005-11-28 |
2012-04-17 |
Gtx, Inc. |
Nuclear receptor binding agents
|
|
JP5405122B2
(ja)
|
2005-12-21 |
2014-02-05 |
ワイス・エルエルシー |
低粘度のタンパク質製剤およびその用途
|
|
WO2008133722A2
(en)
|
2006-11-10 |
2008-11-06 |
Ucb Pharma S.A. |
Anti human sclerostin antibodies
|
|
SI3345607T1
(sl)
*
|
2006-12-29 |
2023-03-31 |
Ossifi-Mab Llc |
Postopki spreminjanja rasti kosti z dajanjem antagonista ali agonista SOST ali WISE
|
|
EP2131860B1
(en)
|
2007-03-20 |
2013-12-18 |
Eli Lilly & Company |
Anti-sclerostin antibodies
|
|
EP2139507A4
(en)
|
2007-04-27 |
2012-06-06 |
Unigene Lab Inc |
METHODS AND COMPOSITIONS FOR PROMOTING AND CONSERVING BONE GROWTH
|
|
CL2008002775A1
(es)
|
2007-09-17 |
2008-11-07 |
Amgen Inc |
Uso de un agente de unión a esclerostina para inhibir la resorción ósea.
|
|
AR068767A1
(es)
*
|
2007-10-12 |
2009-12-02 |
Novartis Ag |
Anticuerpos contra esclerostina, composiciones y metodos de uso de estos anticuerpos para tratar un trastorno patologico mediado por esclerostina
|
|
CN105859889B
(zh)
*
|
2010-11-17 |
2020-01-07 |
中外制药株式会社 |
具有代替凝血因子viii的功能的功能的多特异性抗原结合分子
|
|
US8790651B2
(en)
*
|
2011-07-21 |
2014-07-29 |
Zoetis Llc |
Interleukin-31 monoclonal antibody
|
|
JP6511233B2
(ja)
|
2014-08-28 |
2019-05-15 |
株式会社竹中工務店 |
柱脚部と鉄骨梁との接合構造
|